A_DT number_NN of_IN prostate_NN cancer_NN nomograms_NNS which_WDT combine_VBP clinical_JJ and\/or_CC pathologic_JJ factors_NNS to_TO predict_VB an_DT individual_JJ patients_NNS probability_NN of_IN disease_NN recurrence_NN or_CC survival_NN have_VBP been_VBN published_VBN ,_, e.g._FW ,_, -LRB-_-LRB- 14_CD -RRB-_-RRB- =_JJ -_: =[_NN 6_CD -RRB-_-RRB- -_: =_JJ -_: -LRB-_-LRB- 11_CD -RRB-_-RRB- ._.
The_DT postoperative_JJ nomogram_NN developed_VBN by_IN Kattan_NNP et_FW al._FW -LRB-_-LRB- 14_CD -RRB-_-RRB- is_VBZ widely_RB used_VBN by_IN clinicians_NNS and_CC allows_VBZ a_DT prediction_NN of_IN the_DT probability_NN of_IN disease_NN recurrence_NN for_IN patients_NNS who_WP have_VBP received_VBN radical_JJ p_NN
